Safety, Tolerability and Efficacy of SNA-120 for Treatment of Pruritus and Psoriasis in Subjects Treated With Calcipotriene

NCT03448081 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

73

Enrollment

INDUSTRY

Sponsor class

Conditions

Pruritus
Psoriasis

Interventions

DRUG: SNA-120
DRUG: Placebo
DRUG: Calcipotriene

Sponsor

Sienna Biopharmaceuticals